| Roche Pharma (Schweiz) AG - Zelboraf 240 mg, Filmtabletten | | 62139 | | 01 | | Zelboraf 240 mg | | Filmtabletten | | L01EC01 | | Vemurafenib | | 18.10.2011 | | |
| | Composition | | vemurafenibum 240 mg, hypromellosi acetas succinas, silica colloidalis anhydrica, carmellosum natricum conexum, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (rubrum), pro compresso obducto, natrium 5.6 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Vemurafenibum | 240 mg |
| | BAG: Active Agent | Dose |
|---|
| Vemurafenibum | 240 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Rubrum) | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosi Acetas Succinas | | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Sodium | 5.6 mg | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 56 Tablet(s) | 1465.88 | 1610.65 | A | SL | No |
|
|
